story of the week
Trastuzumab Emtansine Effective in Previously Treated HER2+ Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab Emtansine Versus Capecitabine Plus Lapatinib in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (EMILIA): A Descriptive Analysis of Final Overall Survival Results From a Randomised, Open-Label, Phase 3 Trial
Lancet Oncol 2017 May 16;[EPub Ahead of Print], V Diéras, D Miles, S Verma, M Pegram, M Welslau, J Baselga, IE Krop, K Blackwell, S Hoersch, J Xu, M Green, L GianniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.